While low cost cards can assist alleviate the burden of large drug fees while in the temporary, they don't address the systemic problems driving up prescription charges from the U.S. Broader plan changes could deal with the foundation triggers of mounting drug rates, which include insufficient transparency in pricing plus the position of intermedia